NOTES PAYABLE (Details Textual) (USD $)	1 Months Ended	12 Months Ended		13 Months Ended						0 Months Ended	12 Months Ended			0 Months Ended
	Oct. 31, 2009	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 29, 2011	Nov. 01, 2011	Oct. 27, 2011	Dec. 31, 2012 Ariston [Member]	Dec. 31, 2011 Ariston [Member]	Mar. 08, 2010 Icon Clinical Research [Member]	Dec. 31, 2012 Icon Clinical Research [Member]	Dec. 31, 2011 Icon Clinical Research [Member]	Mar. 31, 2011 Icon Clinical Research [Member]	Mar. 08, 2010 Convertible Notes Payable [Member]	Dec. 31, 2012 Exchange Transaction [Member]	Mar. 31, 2011 Before Amendment [Member] Icon Clinical Research [Member]	Mar. 31, 2011 After Amendment [Member] Icon Clinical Research [Member]
Settlement Agreement Payment	$ 200,000
Waiver Period		13 months
Promissory Note Issued							250,000
Debt Instrument Renegotiated Price						200,000
Debt Instrument, Interest Rate, Stated Percentage		5.00%		5.00%				5.00%		5.00%	5.00%					5.00%	8.00%
Percentage Of Cash Proceeds From Operation To Repay Interest On Convertible Debt		50.00%
Debt Instrument, Convertible, Conversion Price									$ 10					$ 1,125			$ 562.5
Long-term Debt, Gross		17,727,000	16,883,000	17,727,000	16,876,000
Accounts Payable										1,275,188
Payments of short-term loans		200,001	0	200,001						275,188
Debt Instrument, Periodic Payment, Principal										27,778
One Time Settlement Amount For Waiver Of Interest and Principal Payments													100,000
Interest and Debt Expense											61,571
Notes payable, current portion		677,778	877,778	677,778							677,778	677,778
Interest Payable											123,511	61,941
Debt Instrument Repayment Term										36 months
Debt Instrument, Maturity Date	Feb. 15, 2012													Mar. 08, 2015
Total		$ 3,156,876	$ 4,172,575	$ 3,156,876											$ 3,287,700